← Eichor
Study identifier: NCT06319885 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Text Messaging to Reduce High-risk Alcohol Use Among Older Adults

Condition: Hazardous Alcohol Use  ·  Sponsor: University of Southern Denmark

PhaseNA
Planned participants60
Who can joinAll sexes, 55 Years to 80 Years
Healthy volunteersNo

About this study

High-risk drinking is very prevalent among Danes aged 55+. It poses a serious risk to health and independent living, burdening health care systems and family members. Measures to reduce high-risk alcohol use in this growing group at need are urgently needed. A recent small study from the US shows that text messaging reduces high-risk alcohol intake in older adults. The investigators will conduct a pilot study with the same intervention in Denmark, with adaptations to language and culture. The pilot study will investigate among Danish older adults whether text messaging is well-accepted by participants and feasible in terms of reducing 1) high-risk drinking and 2) commonly accompanying problems with daily functioning, social relationships, and mental and physical health. The pilot-trial will include n=60 adults aged 55-80 years who will receive alcohol-related text messages (within a secure app for data protection purposes) over 12 weeks. Assessments will include a baseline assessment and a post-assessment.

This description comes directly from the study's public registry record.

Talk to the study team

Silke Behrendt, PhD  ·  +4593507195  ·  sbehrendt@health.sdu.dk

Anette S Nielsen, PhD  ·  0045 29 13 58 25  ·  ansnielsen@health.sdu.dk

Always discuss trial participation with your own doctor first.

Locations (1)

University of Southern Denmark, Department of PsychologyOdense, Southern Denmark, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06319885